The sales declined to Rs. 1340.00 millions for the March 2026 quarter as compared to Rs. 1484.63 millions during the corresponding quarter last year.A comparatively good net profit growth of 40.42% to Rs. 245.76 millions was reported for the quarter ended March 2026 compared to Rs. 175.02 millions of previous same quarter.The company reported a good operating profit of 357.16 millions compared to 243.75 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	1340.00	1484.63	-9.74	4865.73	4628.49	5.13	4865.73	4628.49	5.13
Other Income	142.28	69.03	106.11	309.66	171.91	80.13	309.66	171.91	80.13
PBIDT	357.16	243.75	46.53	1081.25	706.97	52.94	1081.25	706.97	52.94
Interest	3.67	0.89	312.36	11.05	8.50	30.00	11.05	8.50	30.00
PBDT	353.45	242.94	45.49	1070.57	698.53	53.26	1070.57	698.53	53.26
Depreciation	24.82	12.86	93.00	65.32	51.94	25.76	65.32	51.94	25.76
PBT	328.63	230.08	42.83	1005.25	646.59	55.47	1005.25	646.59	55.47
TAX	82.87	55.06	50.51	245.17	157.87	55.30	245.17	157.87	55.30
Deferred Tax	11.21	10.05	11.54	18.14	13.34	35.98	18.14	13.34	35.98
PAT	245.76	175.02	40.42	760.08	488.72	55.52	760.08	488.72	55.52
Equity	940.00	940.00	0.00	940.00	940.00	0.00	940.00	940.00	0.00
PBIDTM(%)	26.65	16.42	62.34	22.22	15.27	45.48	22.22	15.27	45.48

Syncom Formulations (India) Ltd.